Investors in companies manufacturing Covid-19 vaccines must use their influence to ensure that supplies of urgently needed life-saving vaccines reach low- and lower-middle-income countries, Amnesty International said today ahead of the Annual General Meetings (AGM) of Johnson and Johnson, Moderna and Pfizer on 28 April and AstraZeneca on 29 April. With the World Health Organization’s (WHO) global target of a 70% vaccination rate in every country by July 2022 on course to be missed by a significant margin, pharmaceutical companies continue to obstruct fair access to Covid-19 vaccines by monopolizing technology, blocking and …